Medicine
Vigamox 5 mg/mL eye drops
Vigamox 5 mg/mL eye drops is a prescription medicine containing Moxifloxacin for ophthalmic use, marketed by Harrow Eye, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 2°C to 25°C (36°F to 77°F).
Key facts
- Active ingredient (INN)
- Moxifloxacin
- Brand
- Vigamox
- Strength
- 5 mg/mL
- Dosage form
- Eye drops
- Route
- Ophthalmic
- Packs
- 1 bottle
- Marketing authorisation holder
- Harrow Eye
- Manufacturer
- Harrow Eye
- Origin register
- US FDA, United States
- Storage
- Store at 2°C to 25°C (36°F to 77°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- J01MA14 Moxifloxacin
- HS code (indicative)
- 3004.20Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 1 July 2024
- Identifiers
- RxCUI 403818, 404473DailyMed set ID 12053b08-7e66-c6f3-e063-6394a90a9cd9NDC 82667-700Application NDA021598
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 bottle in 1 carton / 3 mL in 1 bottle | 82667-700-03 | Harrow Eye | 1 July 2024 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 10 December 1999 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Moxifloxacin 5 mg/mL eye drops.
Other strengths and forms of Moxifloxacin
Clinical summary
Moxifloxacin is a fluoroquinolone antibacterial indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of organisms. It is available as eye drops, tablets and injection for ophthalmic, oral and intravenous use. MedsAcross supplies Moxifloxacin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about MoxifloxacinFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- VIGAMOX prescribing information (Harrow Eye) · U.S. National Library of Medicine, DailyMed
Need Vigamox 5 mg/mL eye drops for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.